SEC Comment Letter 0000000000-24-012829 to Evolent Health, Inc. (EVH)

Evolent Health, Inc.
Date: Nov. 20, 2024 · CIK: 0001628908 · Accession: 0000000000-24-012829

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-37415

Date

November 20, 2024

Author

Not clearly detected

Form

UPLOAD

Company

Evolent Health, Inc.

Letter

November 20, 2024 John Johnson Chief Financial Officer Evolent Health, Inc. 1812 N. Moore Street Suite 1705 Arlington, VA 22209 Re:Evolent Health, Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-37415 Dear John Johnson: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Trade & Services

Show Raw Text

November 20, 2024
John Johnson
Chief Financial Officer
Evolent Health, Inc.
1812 N. Moore Street
Suite 1705
Arlington, VA 22209
Re:Evolent Health, Inc.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-37415
Dear John Johnson:
            We have completed our review of your filings. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Trade & Services

SecProbe.io